G
Glooko
Biotech & Life Sciences · Palo Alto, United States · Founded 2010
Unified platform for diabetes management MoreLess
Glooko provides a unified platform for diabetes management, connecting patients, providers, and devices to simplify diabetes care. The platform syncs data from various diabetes devices, including blood glucose meters, insulin pumps, and smart pens, to provide actionable insights for better treatment decisions. The company serves both people with diabetes and healthcare providers, including endocrinologists, nurses, diabetes educators, and primary care providers.
Glooko's platform aims to streamline workflows for healthcare professionals and deliver measurable health outcomes for patients. By unifying data from a variety of devices, Glooko makes diabetes management easier and more efficient. The company operates in the digital health and diabetes care market, offering a data management solution that enhances the connection between patients and their care teams.
Keywords: diabetes management, digital health, data platform, patient monitoring, healthcare data, medical devices, chronic care, remote patient monitoring, health-tech, connected care
Company overview
Glooko company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2010
- Headquarters
- Palo Alto, United States
- Employees
- 237
- Open positions
- None listed
- Dealroom signal
- 68.8
- Investment activity
- 4 companies · latest Sep 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Glooko funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | Oct 2024 | $100M | $400M | Health Catalyst Capital · Georgian · Canaan | ↗ |
| SERIES DOther financing | Mar 2021 | $30M | $175M | Canaan · Health Catalyst Capital · Novo Nordisk · Mayo Clinic | — |
| SERIES COther financing | Jun 2017 | $39M | $154M | Social Capital · Samsung Next · Georgian · Medtronic | ↗ |
| SERIES COther financing | Sep 2016 | $8M | $32M | Social Capital · Canaan · Samsung Ventures · Samsung Next | — |
| SERIES BOther financing | Mar 2015 | $17M | $66M | Medtronic · Samsung Ventures · Social Capital · Lifeforce Ventures | — |
| SERIES AOther financing | Jan 2014 | Social Capital · Samsung Ventures · Lifeforce Ventures · Samsung Next | — | ||
| SERIES AOther financing | Jan 2012 | Social Capital | — | ||
| SEEDOther financing | Nov 2010 | Social Capital | — |
Growth signals
Glooko website traffic
Latest recorded traffic for Glooko is 210K monthly website visits, up 40% over the last three months. Glooko's team declined 13.8% over the past year.
Hiring
Open positions at Glooko
Current openings linked to this company in Dealroom.
Comparisons
Glooko compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Glooko investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Monarch Medical TechnologiesIdaho Falls, United StatesA digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike
→
DIABNEXTTaiwanSet of connected devices and software that collect and analyze the main metrics of diabetes
→
xbirdBerlin, GermanyAI based personalization of diabetes therapy
→
DiasendGöteborgs Stad, SwedenDiasend® makes management of your diabetes data simple. One solution, no fuss. FREE for home users! diasend® is built on your feedback, so make yourself heard!
→
Talent graph
Glooko's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Glooko has talent and traffic
team presence
In the news
Latest news about Glooko
Recent press, funding announcements, and product moves mentioning Glooko — open to read from the original sources.
Market sentiment
What the market is saying about Glooko
An AI-synthesized read of the highest-engagement posts about Glooko on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Glooko’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.